Blog

May 28, 2024, 14:05

Timothée Olivier: How applying FDA censoring rules can double the PFS benefit by Vinay Prasad

Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared a post on X:

“How applying FDA censoring rules can double the PFS benefit?

Nice coverage by Vinay Prasad in the Drug Development Letter of our paper recently published in EJC!”

Read the article.
Sources: Timothée Olivier/X
.

cancer cancer treatment efficacy clinical trial methodology Drug Development Letter EJC paper FDA censoring rules HUG - Geneva University Hospitals Medical Advancements OncoDaily Oncology oncology research progression-free survival (PFS) benefit regulatory guidelines Timothée Olivier Vinay Prasad

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage